Search Results - Eva J. Gordon
- Showing 1 - 3 results of 3
-
1
Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient by David Parker, Jessica Zambelli, Montana Kay Lara, Trevor Hamilton Wolf, Amber McDonald, Erica Lee, Lotfi Abou-Elkacem, Eva J. Gordon, Richard P. Baum
Published in Frontiers in Oncology (2023-04-01)Get full text
Article -
2
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition by Afsaneh Barzi, Caroline M. Weipert, Carin R. Espenschied, Victoria M. Raymond, Andrea Wang-Gillam, Mohammad Amin Nezami, Eva J. Gordon, Daruka Mahadevan, Kabir Mody
Published in Frontiers in Oncology (2024-02-01)Get full text
Article -
3
Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma by Marwah Al-Aloosi, Amanda M. Prechtl, Payel Chatterjee, Brady Bernard, Brady Bernard, Christopher J. Kemp, Rachele Rosati, Robert L. Diaz, Lauren R. Appleyard, Shalini Pereira, Alex Rajewski, Amber McDonald, Eva J. Gordon, Carla Grandori
Published in Frontiers in Oncology (2024-01-01)Get full text
Article
